Cullinan Oncology LLC (CGEM) — Long-term Investment Intensity
Cullinan Oncology LLC (CGEM) has a Long-term Investment Intensity of 13.0% as of December 2025. Long-term investments of $58.27 Million represent 13.0% of total assets of $448.37 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Cullinan Oncology LLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Cullinan Oncology LLC Long-term Investment Intensity (2021–2025)
This chart shows how Cullinan Oncology LLC's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 13.0%, reflecting long-term investments of $58.27 Million against total assets of $448.37 Million USD. Explore how well can Cullinan Oncology LLC service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Cullinan Oncology LLC (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Cullinan Oncology LLC from 2021 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see CGEM market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 13.0% | $58.27 Million | $448.37 Million | ▼ -19.9 pp |
| 2024 | 32.9% | $204.44 Million | $621.82 Million | ▲ +18.5 pp |
| 2022 | 14.4% | $80.88 Million | $561.12 Million | ▼ -17.7 pp |
| 2021 | 32.1% | $140.40 Million | $437.19 Million | — |